CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +97,417 | 97,417 | ||
| 2026-06-16 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-16 | Strahley John Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-06-05 | SCHULER JACK W 10% owner | Purchase | +222,222 | $0.45 | $100K | 4,046,051 |
| 2026-06-05 | SCHULER JACK W 10% owner | Purchase · Warrant (Right to Buy) | +300,000 | 300,000 | ||
| 2025-12-02 | Hundorfean Cynthia D Director | Grant or award · Stock Option (Right to Buy) | +238,085 | 238,085 | ||
| 2025-12-02 | Fraser John D Director | Grant or award · Stock Option (Right to Buy) | +314,811 | 314,811 | ||
| 2025-12-02 | Wood Jane Pine Director | Grant or award · Stock Option (Right to Buy) | +135,592 | 135,592 | ||
| 2025-12-02 | Parnell Winfred Director | Grant or award · Stock Option (Right to Buy) | +185,178 | 185,178 | ||
| 2025-12-02 | cohen Jeffrey k Director | Grant or award · Stock Option (Right to Buy) | +213,518 | 213,518 | ||
| 2025-12-02 | Beausang Ellen Director | Grant or award · Stock Option (Right to Buy) | +198,097 | 198,097 | ||
| 2025-09-17 | cohen Jeffrey k Director | Other acquisition | +11,112 | $0.45 | $5K | 386,018 |
| 2025-09-17 | Fraser John D Director | Purchase | +16,389 | $0.45 | $7K | 566,393 |
| 2025-09-17 | Fraser John D Director | Purchase · Warrant (Right to Buy) | +12,292 | 12,292 | ||
| 2025-09-17 | cohen Jeffrey k Director | Purchase | +55,556 | $0.45 | $25K | 374,906 |
| 2025-09-17 | cohen Jeffrey k Director | Purchase · Warrant (Right to Buy) | +41,667 | 41,667 | ||
| 2025-09-17 | SCHULER JACK W 10% owner | Purchase | +1,111,111 | $0.45 | $500K | 3,823,829 |
| 2025-09-17 | SCHULER JACK W 10% owner | Purchase · Warrant (Right to Buy) | +833,333 | 833,333 | ||
| 2025-09-17 | cohen Jeffrey k Director | Purchase | +55,556 | $0.45 | $25K | 375,697 |
| 2025-09-17 | cohen Jeffrey k Director | Purchase · Warrant (Right to Buy) | +41,667 | 491,985 |
Page 1 of 15 · 296 trades